Which has grown faster, JANX or PCRX?

Over the past five years, JANX grew revenue faster — JANX at a 105.89% CAGR versus PCRX at 8.20%.

Is JANX or PCRX more profitable?

PCRX runs the higher net margin — JANX at -321.81% versus PCRX at 1.96%.

How have JANX and PCRX total returns compared?

Over the past 5 years, JANX delivered -6.45% and PCRX delivered -12.27% annualized total return. Past performance doesn't predict future results.

Janux Therapeutics, Inc. (JANX) vs Pacira BioSciences, Inc. (PCRX)

A side-by-side comparison of Janux Therapeutics, Inc. and Pacira BioSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

JANX

Janux Therapeutics, Inc.

$1.02B

$16.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PCRX

Pacira BioSciences, Inc.

$974M

$24.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — JANX vs PCRX

growth of $100 · dividends reinvested · last 5y

JANX -34.2% (-8.0%/yr)PCRX -57.7% (-15.8%/yr)JANX compounded faster over this window

JANX PCRX

JANX vs PCRX: by the numbers

•JANX is the larger company ($1.02B vs $974M market cap).
•PCRX is profitable (1.96% net margin) while JANX runs a net loss (-321.81%).
•JANX grew revenue faster over the past five years (105.89% vs 8.20% CAGR).

Metrics side by side

Valuation

Metric	JANX	PCRX
P/E ratio	N/A	70.48
P/S ratio	32.12	1.31
P/B ratio	1.10	1.45
EV / EBITDA	N/A	11.39
FCF yield	N/A	18.43%

Profitability

Metric	JANX	PCRX
Gross margin	79.71%	79.21%
Operating margin	-1576.67%	2.47%
Net margin	-321.81%	1.96%
ROE	-11.06%	2.18%
ROIC	-15.15%	1.35%

Growth (annualized)

Metric	JANX	PCRX
Revenue CAGR (5Y)	105.89%	8.20%
EPS CAGR (5Y)	N/A	-45.77%
FCF CAGR (5Y)	N/A	16.72%
Total return CAGR (5Y)	-6.45%	-12.27%

Frequently asked

Which has grown faster, JANX or PCRX?: Over the past five years, JANX grew revenue faster — JANX at a 105.89% CAGR versus PCRX at 8.20%.
Is JANX or PCRX more profitable?: PCRX runs the higher net margin — JANX at -321.81% versus PCRX at 1.96%.
How have JANX and PCRX total returns compared?: Over the past 5 years, JANX delivered -6.45% and PCRX delivered -12.27% annualized total return. Past performance doesn't predict future results.

Go deeper

Full JANX analysis Full PCRX analysis Interactive comparison tool

Dig into the metrics

Pacira BioSciences P/E ratio Janux Therapeutics ROE Pacira BioSciences ROE Janux Therapeutics operating margin Pacira BioSciences operating margin Janux Therapeutics revenue growth Pacira BioSciences revenue growth Janux Therapeutics free cash flow Pacira BioSciences free cash flow

Janux Therapeutics & Pacira BioSciences appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.